THE TAPE
PLD · REITs · $119.0B

PROLOGIS, INC.

$127.60▼ −0.83%
Last close
Relative strength
31RS
of 99, against every stock▲ +3 on the month
Turning up
Caution
−8.1%
six months against REITs
52-week range
−16.8%
from the high
$121.40$153.35
Setup
vcpplayed out
−12.3%
against the pivot at $145.44
No report date on the calendar.
Growth FLATProof SHOWN
Quarter to Mar 31, revenue +7% on a year ago
11/16 O 129.01 H 129.32 L 127.33 Vol 3.1M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

RS31
vs pivot−12.27%
Tightening1.29×
Dry-up1.18×
Up/down vol-0.24
From high17%
played out2 of 9checks
Previous breakout trailed out ▼ −4.19% in Jan
Turning up
Support and resistance
Support below
$126.75
-0.7% · tested 3× · last 6 sessions ago
Resistance above
$136.62
+7.1% · tested 7× · last 24 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 5.0 weeks and fell 5% from its ceiling at its deepest. The pivot is $145.44, and the stock closed 12.3% below it. Its relative strength rating is 31.

Against its industry
CautionBehind its industry over all three, in an industry that is not ahead of the S&P 500.
One month against its industry
-1.6%
Three months against its industry
-3.6%
Six months against its industry
-8.1%

Read against an equal-weighted index of REITs, which is -2.6% against the S&P 500 over six months Not aligned.

Also on
Peers
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 3.9% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$8.9B
+7.4% year on year
Operating margin
52.4%
Net margin
41.5%
Free cash flow
$5.1B
4.3% of market cap
Price to sales
13.3×
Price to earnings
32.0×

Twelve months to Mar 31, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Oct 15

The prior quarter: the 10-Q for this report is not filed yet.

Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$2.3B
+2.0% QoQ · +7.4% YoY
Gross margin
—
Net income
$982.0M
Positive
Free cash flow
$1.3B
Cash generating

What the numbers say

  • Revenue +7.4% year over year, +2.0% on the quarter
  • Good: Profitable: net income $982M, operating margin 52.7%
  • Good: Cash generating: operating cash flow $1.29B, free cash flow $1.29B
  • Weak: Net debt $33.81B · cash $861M
Revenue by quarter
Free cash flow
Net income
shares +0.2% in a year · net debt $33.8B
Final read
Growth: FLAT · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is the balance sheet: net debt $33.81B · cash $861M.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 1 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 added.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Red flag in a filingFiling · 2026-10-31
material weakness
No measurable effect: stocks behave like random ones over the next three sessions (1,160 cases over 54 nights).
Earnings comingEvent · 2026-10-15
reports 2026-10-15 bmo
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).
Earnings comingEvent · 2026-10-14
reports 2026-10-15 bmo
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).
Unusual volumeTape · 2026-09-19
6.0 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
2
$8,035,050 total

Sold: Moghadam Hamid, Arndt Timothy D.

Not counted above: 3 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-09-17 BITA CRISTINA GABRIELA · Directoroption exercise1,687
2026-09-17 BITA CRISTINA GABRIELA · Directoroption exercise1,128
2026-09-17 FOTIADES GEORGE L · Directoroption exercise1,687
2026-07-16 Moghadam Hamid · Directorsell50,000$7,495,500
2026-06-15 Arndt Timothy D · Chief Financial Officersell3,597$539,550

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What lines up

2 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy6
Buy8
Hold3
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray
5w · 5%

The most recent of 2 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
PROLOGIS, INC. (PLD) — The Tape